Compound ID | 2202
Synonym(s): LCB10-0200
Class: Beta-lactam
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Pseudomonas aeruginosa including beta-lactamase producing strains |
| Description: | Synthetic compound; siderophore-cephalosporin conjugate; combination with GT-055 also shows activity against Burkholderia pseudomallei and Yersinia pestis |
| Institute where first reported: | LegoChem Biosciences (Daejeon, South Korea) and Geom Therapeutics (San Francisco, CA, USA) |
| Year first mentioned: | 2017 |
| Highest developmental phase: | Phase 1 (Australia ACTRN12618001980224) |
| Development status: | Discontinued |
| Reason Dropped: | Unspecified safety reasons (suspected hepatotoxicity) |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/145283404 |
| Guide to Pharmacology: | GT-1 |
| Citations: |
|
| Patent: | WO2017055922 |